Predicting personalized cumulative live birth following in vitro fertilization.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
02 2022
Historique:
received: 11 06 2021
revised: 14 09 2021
accepted: 14 09 2021
pubmed: 23 10 2021
medline: 1 3 2022
entrez: 22 10 2021
Statut: ppublish

Résumé

To develop in vitro fertilization (IVF) prediction models to estimate the individualized chance of cumulative live birth at two time points: pretreatment (i.e., before starting the first complete cycle of IVF) and posttreatment (i.e., before starting the second complete cycle of IVF in those couples whose first complete cycle was unsuccessful). Population-based cohort study. National data from the Society for Assisted Reproductive Technology (SART) Clinic Outcome Reporting System. Based on 88,614 women who commenced IVF treatment using their own eggs and partner's sperm in SART member clinics. Not applicable. The pretreatment model estimated the cumulative chance of a live birth over a maximum of three complete cycles of IVF, whereas the posttreatment model did so over the second and third complete cycles. One complete cycle included all fresh and frozen embryo transfers resulting from one episode of ovarian stimulation. We considered the first live birth episode, including singletons and multiple births. Pretreatment predictors included woman's age (35 years vs. 25 years, adjusted odds ratio 0.69, 95% confidence interval 0.66-0.73) and body mass index (35 kg/m The focus of previous IVF prediction models based on US data has been cumulative live birth excluding cycles involving frozen embryos. These novel prediction models provide clinically relevant estimates that could help clinicians and couples plan IVF treatment at different points in time.

Identifiants

pubmed: 34674824
pii: S0015-0282(21)02053-7
doi: 10.1016/j.fertnstert.2021.09.015
pii:
doi:

Substances chimiques

Biomarkers 0
Anti-Mullerian Hormone 80497-65-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

326-338

Informations de copyright

Copyright © 2021 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

David J McLernon (DJ)

Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom. Electronic address: d.mclernon@abdn.ac.uk.

Edwin-Amalraj Raja (EA)

Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.

James P Toner (JP)

Department of Gynecology and Obstetrics, Emory University, Atlanta, Georgia.

Valerie L Baker (VL)

Division of Reproductive Endocrinology and Infertility, Johns Hopkins University School of Medicine, Lutherville, Maryland.

Kevin J Doody (KJ)

Center for Assisted Reproduction, Bedford, Texas.

David B Seifer (DB)

Division of Reproductive Endocrinology and Infertility, Yale University School of Medicine, New Haven, Connecticut.

Amy E Sparks (AE)

Center for Advanced Reproductive Care, University of Iowa Health Care, Iowa City, Iowa.

Ethan Wantman (E)

Redshift Technologies, Inc., New York, New York.

Paul C Lin (PC)

Seattle Reproductive Medicine, Seattle, Washington.

Siladitya Bhattacharya (S)

School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom.

Bradley J Van Voorhis (BJ)

Department of Obstetrics and Gynecology, University of Iowa Health Care, Iowa City, Iowa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH